Methods of Treating Central Nervous System Disorders via Administration of Nanoparticles of an mTOR Inhibitor and an Albumin
Copyright © Targeted News Service 2024
2024-04-02
ALEXANDRIA, Virginia, April 2 -- ABRAXIS BIOSCIENCE, LLC, Summit, New Jersey has been assigned a patent (No. US 11944708 B2, initially filed Sept. 17, 2020) developed by Neil P. Desai, Pacific Palisades, California, and Shihe Hou, Millington, New Jersey, for "Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin." . . .